ClinicalTrials.Veeva

Menu

Reliability of Multiple-Repetition-Maximum Tests in Patients with Cardiovascular Disease or Risk Factors

T

Technical University of Munich

Status

Not yet enrolling

Conditions

Arterial Hypertension
Diabetes Mellitus
Atrial Fibrillation (AF)
Heart Failure
Coronary Heart Disease (CHD)

Study type

Observational

Funder types

Other

Identifiers

NCT06796582
2025-27-S-CB

Details and patient eligibility

About

Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (based on different formulas) between two Multiple-RM tests with different weight in 50 patients with cardiovascular disease (heart failure, coronary heart disease, atrial fibrillation) or cardiovascular risk factors (type 2 diabetes, arterial hypertension).

Enrollment

50 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 50 years
  • At least one of the following cardiovascular diseases / risk factors:
  • Heart failure
  • Coronary heart disease
  • Atrial fibrillation
  • Arterial hypertension
  • Type 2 diabetes mellitus
  • Clinically stable for ≥ 4 weeks
  • Medical clearance to perform resistance training / strength testing
  • Signed written informed consent

Exclusion criteria

  • Pregnancy
  • Acute infection
  • Chronic joint inflammation
  • Knee, hip, ankle, wrist, elbow or shoulder pain
  • Known osteoporosis (T-value ≤ -2.5)
  • Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic)
  • Known cerebral or thoracic aneurysm

Trial contacts and locations

0

Loading...

Central trial contact

Stephan Mueller, Dr rer nat

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems